<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Fancy NN</submitter><funding>UK Dementia Research Institute</funding><funding>Medical Research Council</funding><funding>Alzheimer’s Research UK</funding><pagination>78</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11065703</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>147(1)</volume><pubmed_abstract>Aging is associated with cell senescence and is the major risk factor for AD. We characterized premature cell senescence in postmortem brains from non-diseased controls (NDC) and donors with Alzheimer's disease (AD) using imaging mass cytometry (IMC) and single nuclear RNA (snRNA) sequencing (> 200,000 nuclei). We found increases in numbers of glia immunostaining for galactosidase beta (> fourfold) and p16&lt;sup>INK4A&lt;/sup> (up to twofold) with AD relative to NDC. Increased glial expression of genes related to senescence was associated with greater β-amyloid load. Prematurely senescent microglia downregulated phagocytic pathways suggesting reduced capacity for β-amyloid clearance. Gene set enrichment and pseudo-time trajectories described extensive DNA double-strand breaks (DSBs), mitochondr</pubmed_abstract><journal>Acta neuropathologica</journal><pubmed_title>Characterisation of premature cell senescence in Alzheimer's disease using single nuclear transcriptomics.</pubmed_title><pmcid>PMC11065703</pmcid><funding_grant_id>MR/P024572/1</funding_grant_id><pubmed_authors>Smith AM</pubmed_authors><pubmed_authors>Davey K</pubmed_authors><pubmed_authors>Tsartsalis S</pubmed_authors><pubmed_authors>Boulger S</pubmed_authors><pubmed_authors>Papageorgopoulou M</pubmed_authors><pubmed_authors>Jenkyns MH</pubmed_authors><pubmed_authors>McGarry A</pubmed_authors><pubmed_authors>Adair E</pubmed_authors><pubmed_authors>Khozoie C</pubmed_authors><pubmed_authors>Chau V</pubmed_authors><pubmed_authors>Thomas M</pubmed_authors><pubmed_authors>Willumsen N</pubmed_authors><pubmed_authors>Gomez-Nicola D</pubmed_authors><pubmed_authors>Caramello A</pubmed_authors><pubmed_authors>Jackson JS</pubmed_authors><pubmed_authors>Fancy NN</pubmed_authors><pubmed_authors>Muirhead RCJ</pubmed_authors><pubmed_authors>Schneegans E</pubmed_authors><pubmed_authors>Matthews PM</pubmed_authors><pubmed_authors>Cheung TKD</pubmed_authors></additional><is_claimable>false</is_claimable><name>Characterisation of premature cell senescence in Alzheimer's disease using single nuclear transcriptomics.</name><description>Aging is associated with cell senescence and is the major risk factor for AD. We characterized premature cell senescence in postmortem brains from non-diseased controls (NDC) and donors with Alzheimer's disease (AD) using imaging mass cytometry (IMC) and single nuclear RNA (snRNA) sequencing (> 200,000 nuclei). We found increases in numbers of glia immunostaining for galactosidase beta (> fourfold) and p16&lt;sup>INK4A&lt;/sup> (up to twofold) with AD relative to NDC. Increased glial expression of genes related to senescence was associated with greater β-amyloid load. Prematurely senescent microglia downregulated phagocytic pathways suggesting reduced capacity for β-amyloid clearance. Gene set enrichment and pseudo-time trajectories described extensive DNA double-strand breaks (DSBs), mitochondr</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 May</publication><modification>2026-07-15T01:54:37.118Z</modification><creation>2026-06-27T03:18:38.29Z</creation></dates><accession>S-EPMC11065703</accession><cross_references><pubmed>38695952</pubmed><doi>10.1007/s00401-024-02727-9</doi></cross_references></HashMap>